Table 1 Epidemiological characteristics of our patients with anal carcinoma
From: Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients
Description | Numbers |
|---|---|
Mean ± standard deviation | |
Gender | Male: 30 (35 %) |
Female: 56 (65 %) | |
Age | 62 ± 13 years, range: 32–91 years |
Diagnostic delay | 8 ± 12 months, range: 0–62 months |
BMI | 24.7 ± 4.3 kg/m2, range: 17.3–34.7 kg/m2 |
Histology | Squamous carcinoma: 85 (99 %) |
Neuroendocrine carcinoma: 1 (1 %) | |
HIV | Positive: 5, Negative: 1 |
Unknown: 80 | |
T Stage | T1: 8 (9 %) |
T2: 32 (37 %) | |
T3: 25 (29 %) | |
T4: 21 (24 %) | |
TNM Stage | Stage I: 8 (9 %) |
Stage II: 27 (31 %) | |
Stage III: 50 (58 %) | |
Stage IV: 1 (1 %) | |
Tumor site involved | Distal anal channel: 43 (50 %) |
Middle anal channel: 37 (43 %) | |
Proximal anal channel: 54 (63 %) | |
Rectum: 36 (42 %) |